Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Safety Changes: Butisol Sodium, Norditropin, Antibiotics
Link ID 2033
Title FDA Safety Changes: Butisol Sodium, Norditropin, Antibiotics
Url http://www.medscape.com/viewarticle/568152?src=rss
Description The FDA has approved revisions to the safety labeling for butabarbital sodium tablets/oral solution, somatropin recombinant injection and prefilled pen, and certain antimicrobials. Medscape Medical News
Category Articles > Diabetes and Endocrinology
Keywords
Date Jan 3, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Diabetes and Endocrinology
1. First-Line EGFR Inhibition May Benefit Selected Lung Cancer Patients
  There is "strong evidence" that selected groups of patients with advanced non-small cell lung cancer (NSCLC) may benefit from first-line therapy with an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, according to the authors of a report in the March issue of the Journal of Thoracic Oncology. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


2. ADA 2008: Clinical Questions
  Is there value in the early detection of type 2 diabetes? Are there differences between rosiglitazone and pioglitazone? Medscape Diabetes & Endocrinology
Category:   Articles > Diabetes and Endocrinology


3. Dawning of a New Age in Type 2 Diabetes Care: An Expanding Role for Injectable Agents
  Review the challenges that exist in the care of patients with type 2 diabetes, and explore effective strategies to overcome those challenges and successfully integrate injectable agents into patient treatment regimens.
Category:   Articles > Diabetes and Endocrinology


4. Weight-Loss Drugs May Harm Developing Brain: Study
  A drug from a new class of weight-loss treatments disrupted brain development in young mice, U.S. researchers said on Wednesday, raising concerns about using these drugs in children. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


5. Sulfonylurea Safe and Effective for Diabetics With SUR1 Mutations
  Oral sulfonylurea therapy is a safe and effective treatment for patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations and may be able to replace insulin injections, UK researchers report. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS